Anthony Rosenzweig

Dr. Anthony Rosenzweig, Professor of Internal Medicine - Cardiology at the University of Michigan Medical School, is a leading figure in cardiovascular research with a focus on heart failure, exercise physiology, and molecular cardiology. He previously held the Paul Dudley White Professorship of Medicine at Harvard Medical School (2015-2022) and served as Chief of Cardiology and Director of Cardiovascular Research at Massachusetts General Hospital.

• Harvard College (Biochemistry & Molecular Biology)
• Harvard Medical School (MD)
• Massachusetts General Hospital (Residency & Fellowship)
• University of Pennsylvania (Predoctoral Fellowship)
• Harvard Medical School (Postdoctoral Training)

His research spans multiple groundbreaking areas including:

• Exercise-induced cardiac lymphatic remodeling for aging heart inflammation
• miRNA-based therapies for chemotherapy-induced cardiotoxicity
• Traditional Chinese Medicine applications in heart failure treatment (QLQX clinical trials)
• Stem cell-derived cardiomyocyte purification techniques
• Neural pathways linking stress to cardiovascular benefits
• Placental senescence mechanisms in peripartum cardiomyopathy

Scientific contributions include leadership in the QUEST trial showing Qiliqiangxin's efficacy for HFrEF and pioneering work on exercise-regulated noncoding RNAs reversing vascular aging. He currently directs the Stanley and Judith Frankel Institute for Heart and Brain Health at University of Michigan.

• Paul Dudley White Professor of Medicine (2015-2022)
• Inaugural Director, Frankel Institute for Heart and Brain Health
• Leadership roles at MGH, Beth Israel Deaconess, and Harvard Stem Cell Institute

Active in clinical translation, his work bridges molecular cardiology with regenerative medicine and metabolic research, while maintaining significant advisory roles in major cardiovascular organizations.